CASO CLÍNICO
Uso de Fampyra® para la mejoría de la marcha en el paciente con esclerosis múltiple y sus repercusiones en la calidad de vida del paciente
Using Fampyra® for improving gait in patients with multiple sclerosis and impact on the quality of life of patients
Leído
11669
Vecesse ha leído el artículo
1450
Total PDF
10219
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 23 | 5 | 28 |
| 2025 11 | 115 | 18 | 133 |
| 2025 10 | 87 | 7 | 94 |
| 2025 9 | 140 | 9 | 149 |
| 2025 8 | 114 | 14 | 128 |
| 2025 7 | 159 | 7 | 166 |
| 2025 6 | 165 | 5 | 170 |
| 2025 5 | 130 | 3 | 133 |
| 2025 4 | 101 | 7 | 108 |
| 2025 3 | 112 | 9 | 121 |
| 2025 2 | 130 | 5 | 135 |
| 2025 1 | 148 | 12 | 160 |
| 2024 12 | 135 | 5 | 140 |
| 2024 11 | 138 | 3 | 141 |
| 2024 10 | 132 | 6 | 138 |
| 2024 9 | 154 | 24 | 178 |
| 2024 8 | 115 | 8 | 123 |
| 2024 7 | 177 | 1 | 178 |
| 2024 6 | 136 | 4 | 140 |
| 2024 5 | 113 | 2 | 115 |
| 2024 4 | 136 | 10 | 146 |
| 2024 3 | 106 | 8 | 114 |
| 2024 2 | 132 | 3 | 135 |
| 2024 1 | 146 | 7 | 153 |
| 2023 12 | 117 | 6 | 123 |
| 2023 11 | 174 | 2 | 176 |
| 2023 10 | 156 | 6 | 162 |
| 2023 9 | 81 | 2 | 83 |
| 2023 8 | 124 | 5 | 129 |
| 2023 7 | 133 | 3 | 136 |
| 2023 6 | 136 | 11 | 147 |
| 2023 5 | 142 | 1 | 143 |
| 2023 4 | 91 | 14 | 105 |
| 2023 3 | 91 | 4 | 95 |
| 2023 2 | 110 | 7 | 117 |
| 2022 1 | 128 | 6 | 134 |
| 2022 12 | 74 | 10 | 84 |
| 2022 11 | 93 | 4 | 97 |
| 2022 10 | 111 | 11 | 122 |
| 2022 9 | 94 | 11 | 105 |
| 2022 8 | 73 | 12 | 85 |
| 2022 7 | 75 | 13 | 88 |
| 2022 6 | 69 | 14 | 83 |
| 2022 5 | 57 | 11 | 68 |
| 2022 4 | 76 | 19 | 95 |
| 2022 3 | 93 | 14 | 107 |
| 2022 2 | 78 | 9 | 87 |
| 2021 1 | 87 | 9 | 96 |
| 2021 12 | 81 | 14 | 95 |
| 2021 11 | 88 | 14 | 102 |
| 2021 10 | 346 | 25 | 371 |
| 2021 9 | 163 | 10 | 173 |
| 2021 8 | 83 | 14 | 97 |
| 2021 7 | 73 | 14 | 87 |
| 2021 6 | 80 | 10 | 90 |
| 2021 5 | 97 | 13 | 110 |
| 2021 4 | 290 | 40 | 330 |
| 2021 3 | 148 | 9 | 157 |
| 2021 2 | 113 | 23 | 136 |
| 2020 1 | 88 | 25 | 113 |
| 2020 12 | 92 | 14 | 106 |
| 2020 11 | 107 | 15 | 122 |
| 2020 10 | 82 | 8 | 90 |
| 2020 9 | 88 | 13 | 101 |
| 2020 8 | 74 | 8 | 82 |
| 2020 7 | 95 | 5 | 100 |
| 2020 6 | 65 | 7 | 72 |
| 2020 5 | 62 | 18 | 80 |
| 2020 4 | 62 | 9 | 71 |
| 2020 3 | 100 | 13 | 113 |
| 2020 2 | 106 | 9 | 115 |
| 2020 1 | 98 | 14 | 112 |
| 2019 12 | 110 | 11 | 121 |
| 2019 11 | 62 | 14 | 76 |
| 2019 10 | 77 | 12 | 89 |
| 2019 9 | 67 | 7 | 74 |
| 2019 8 | 60 | 12 | 72 |
| 2019 7 | 55 | 26 | 81 |
| 2019 6 | 72 | 30 | 102 |
| 2019 5 | 171 | 67 | 238 |
| 2019 4 | 113 | 34 | 147 |
| 2019 3 | 40 | 12 | 52 |
| 2019 2 | 31 | 17 | 48 |
| 2019 1 | 43 | 21 | 64 |
| 2018 12 | 25 | 5 | 30 |
| 2018 11 | 31 | 12 | 43 |
| 2018 10 | 34 | 10 | 44 |
| 2018 9 | 25 | 8 | 33 |
| 2018 8 | 14 | 18 | 32 |
| 2018 7 | 17 | 6 | 23 |
| 2018 6 | 39 | 6 | 45 |
| 2018 5 | 38 | 14 | 52 |
| 2018 4 | 26 | 5 | 31 |
| 2018 3 | 24 | 2 | 26 |
| 2018 2 | 24 | 2 | 26 |
| 2018 1 | 14 | 2 | 16 |
| 2017 12 | 15 | 2 | 17 |
| 2017 11 | 22 | 6 | 28 |
| 2017 10 | 22 | 4 | 26 |
| 2017 9 | 22 | 4 | 26 |
| 2017 8 | 27 | 8 | 35 |
| 2017 7 | 25 | 5 | 30 |
| 2017 6 | 54 | 18 | 72 |
| 2017 5 | 32 | 11 | 43 |
| 2017 4 | 24 | 39 | 63 |
| 2017 3 | 20 | 19 | 39 |
| 2017 2 | 28 | 4 | 32 |
| 2016 1 | 24 | 5 | 29 |
| 2016 12 | 24 | 10 | 34 |
| 2016 11 | 49 | 36 | 85 |
| 2016 10 | 63 | 26 | 89 |
| 2016 9 | 51 | 12 | 63 |
| 2016 8 | 33 | 10 | 43 |
| 2016 7 | 39 | 8 | 47 |
| 2016 6 | 1 | 1 | 2 |
| 2016 5 | 1 | 3 | 4 |
| 2016 4 | 32 | 21 | 53 |
| 2016 3 | 50 | 25 | 75 |
| 2016 2 | 44 | 22 | 66 |
| 2015 1 | 49 | 30 | 79 |
| 2015 12 | 43 | 27 | 70 |
| 2015 11 | 25 | 11 | 36 |
Mostrar todo